Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$37.69

-0.025 (-0.07%)

12:59
09/23/18
09/23
12:59
09/23/18
12:59

AstraZeneca CEO warns of medicine shortages following Brexit, Reuters reports

Britain could see widespread medicine shortages if there is no deal to prevent friction at the border with the EU after Brexit, according to Reuters, citing a CEO's interview with the Sunday Times. "We have products that go back and forth between the UK and Europe at different stages of manufacturing," Pascal Soriot was quoted as saying. "If drugs are stuck, you have a problem." []:[https://www.reuters.com/article/us-britain-eu-astrazeneca/astrazeneca-ceo-warns-of-medicine-shortages-after-brexit-sunday-times-idUSKCN1M20Y9?feedType=RSS&feedName=businessNews]

AZN AstraZeneca
$37.69

-0.025 (-0.07%)

09/05/18
PIPR
09/05/18
NO CHANGE
Target $48
PIPR
Overweight
Biohaven deal with AstraZeneca enhances leadership, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren says Biohaven Pharmaceutical (BHVN) has licensed a Phase III-ready central nervous system asset from AstraZeneca (AZN) that appears to have $500M-plus potential and "further broadens the company's pipeline." Based on his follow-up with management, the analyst believes the upfront cash payment is modest and that the Phase III trial will be efficient and require an estimated additional spend of $20M. Van Buren thinks the deal is an "attractively structured, efficient and opportunistic" that enhances Biohaven's leadership in CNS drug development. He keeps an Overweight rating on the shares with a $48 price target.
09/06/18
HCWC
09/06/18
NO CHANGE
Target $11
HCWC
Buy
H.C. Wainwright impressed by Checkpoint Therapeutics' first clinical data
H.C. Wainwright analyst Joseph Pantginis says Checkpoint Therapeutics' (CKPT) first clinical data in its history "did not disappoint." The data show a "significant clinical benefit" from CK-101 treatment, Pantginis tells investors in a research note. With these safety and efficacy data in hand, Checkpoint's CK-101 may show competitive clinical advantages versus approved EGFR therapies, including AstraZeneca's Tagrisso, at least in the non-small-cell lung carcinoma indication, the analyst contends. He's "impressed" with the data and notes that Checkpoint management has confirmed its intention to move into a pivotal study in 2019 mimicking the Tagrisso Flaura study. Pantginis has a Buy rating on Checkpoint Therapeutics with an $11 price target.
09/14/18
ROTH
09/14/18
NO CHANGE
Target $33
ROTH
Buy
Roth Capital remains bullish on Stemline after AstraZeneca's Lumoxiti approved
Roth Capital analyst Jotin Marango said he had viewed the BLA review for AstraZeneca's (AZN) Lumoxiti for Hairy Cell Leukemia as a relative gauge of what might happen with Stemline's (STML) Elzonris given what he sees as the similarities between the agents. Lumoxiti's approval makes him more bullish on Stemline ahead of the Q1 of 2019 PDUFA date for Elzonris, said Marango, who raised his assumed probability of success for its BLA to 90% from 75%. He raised his price target on Stemline shares to $33 from $30 and keeps a Buy rating on the stock.
09/17/18
PIPR
09/17/18
NO CHANGE
Target $35
PIPR
Neutral
Piper sees Astra's Lynparza as 'much cleaner' than Tesaro's Zejula
Piper Jaffray analyst Christopher Raymond reiterates a Neutral rating and $35 price target on Tesaro (TSRO) after analyzing a year's worth of adverse event reporting as captured by FDA's Adverse Event Reporting System database, which he obtained through a Freedom of Information Act request. The analyst, while cautioning that the database "likely contains inaccuracies and is far from perfect," is "struck by how much cleaner" AstraZeneca's (AZN) Lynparza appears versus Tesaro's Zejula and Clovis Oncology's (CLVS) Rubraca. Further, Raymond is also surprised that Zejula's adverse events rates do not appear to have decreased in any meaningful way year-over-year, despite Tesaro's active down-dosing efforts. Since the analyst thinks PARPi differentiation remains largely around safety, he lowered his Zejula estimates in 2019 and beyond. Lynparza is likely to maintain the upper hand, Raymond tells investors in a research note.

TODAY'S FREE FLY STORIES

22:45
10/15/18
10/15
22:45
10/15/18
22:45
General news
China's CPI grew 2.5% y/y in September »

China's CPI grew…

PYPL

PayPal

$77.22

-1.8 (-2.28%)

20:49
10/15/18
10/15
20:49
10/15/18
20:49
Recommendations
PayPal analyst commentary at Stifel »

PayPal earnings to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 26

    Nov

ALRM

Alarm.com

$44.50

0.16 (0.36%)

20:45
10/15/18
10/15
20:45
10/15/18
20:45
Upgrade
Alarm.com rating change at First Analysis »

Alarm.com upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

SGBAF

SES S.A.

$0.00

(0.00%)

20:36
10/15/18
10/15
20:36
10/15/18
20:36
Upgrade
SES S.A. rating change at JPMorgan »

SES S.A. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

, UNH

UnitedHealth

$259.80

0.36 (0.14%)

20:25
10/15/18
10/15
20:25
10/15/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

UNH

UnitedHealth

$259.80

0.36 (0.14%)

GS

Goldman Sachs

$215.28

1.37 (0.64%)

MS

Morgan Stanley

$43.45

(0.00%)

BLK

BlackRock

$427.40

-0.18 (-0.04%)

PLD

Prologis

$63.00

0.45 (0.72%)

PGR

Progressive

$66.23

-0.64 (-0.96%)

GWW

Grainger

$318.38

6.75 (2.17%)

OMC

Omnicom

$69.48

0.8 (1.16%)

CMA

Comerica

$83.69

-1.04 (-1.23%)

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

DPZ

Domino's Pizza

$273.13

-4.215 (-1.52%)

FHN

First Horizon

$15.99

-0.11 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 05

    Nov

  • 06

    Nov

  • 27

    Nov

  • 24

    Jan

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

20:13
10/15/18
10/15
20:13
10/15/18
20:13
Recommendations
Twilio, SendGrid analyst commentary at MUFG »

MUFG analyst 'fully…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

20:07
10/15/18
10/15
20:07
10/15/18
20:07
Recommendations
Palo Alto Networks analyst commentary at JPMorgan »

Palo Alto Networks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

SVA

Sinovac Biotech

$7.16

-0.03 (-0.42%)

20:03
10/15/18
10/15
20:03
10/15/18
20:03
Hot Stocks
Sinovac Biotech commences legal proceedings in Hong Kong »

Senior management of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWN

Northwest Natural Gas

$67.70

0.36 (0.53%)

20:01
10/15/18
10/15
20:01
10/15/18
20:01
Hot Stocks
Northwest Natural Water unit to buy Sunriver Water LLC, terms not stated »

NW Natural Water Company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VFC

VF Corp.

$87.65

0.11 (0.13%)

19:53
10/15/18
10/15
19:53
10/15/18
19:53
Initiation
VF Corp. initiated at Wedbush »

VF Corp. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

LVS

Las Vegas Sands

$55.84

-0.32 (-0.57%)

19:39
10/15/18
10/15
19:39
10/15/18
19:39
Upgrade
Las Vegas Sands rating change at HSBC »

Las Vegas Sands upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$72.24

-4.69 (-6.10%)

19:37
10/15/18
10/15
19:37
10/15/18
19:37
Recommendations
Occidental Petroleum analyst commentary at MUFG »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AVMXY

Avita Medical

$0.00

(0.00%)

19:24
10/15/18
10/15
19:24
10/15/18
19:24
Hot Stocks
Avita Medical announces Recell trial results presentation »

AVITA Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.56

-0.2 (-0.13%)

19:16
10/15/18
10/15
19:16
10/15/18
19:16
Hot Stocks
Facebook confirms expanding policies on voter suppression »

Facebook said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

18:58
10/15/18
10/15
18:58
10/15/18
18:58
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: J.B.…

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

SEND

SendGrid

$30.94

0.04 (0.13%)

TWLO

Twilio

$76.26

1.27 (1.69%)

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

ADBE

Adobe

$238.05

-10.84 (-4.36%)

CRY

CryoLife

$30.64

0.42 (1.39%)

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

JELD

Jeld-Wen

$21.31

-0.04 (-0.19%)

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

AGN

Allergan

$183.03

-0.275 (-0.15%)

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

SNAP

Snap

$7.41

0.225 (3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 25

    Oct

  • 30

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 27

    Nov

  • 10

    Dec

SHLD

Sears

$0.31

-0.0901 (-22.52%)

18:43
10/15/18
10/15
18:43
10/15/18
18:43
Hot Stocks
Sears receives court approval of 'first day' motions to support business ops »

Sears Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$97.03

1.63 (1.71%)

18:38
10/15/18
10/15
18:38
10/15/18
18:38
Upgrade
Wabtec rating change at Wellington Shields »

Wabtec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

TGE

Tallgrass Energy

$23.73

0.17 (0.72%)

18:30
10/15/18
10/15
18:30
10/15/18
18:30
Hot Stocks
Tallgrass Energy, Silver Creek Midstream to expand Powder River Basin JV »

Tallgrass Energy and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$113.47

0.86 (0.76%)

, GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

18:21
10/15/18
10/15
18:21
10/15/18
18:21
Hot Stocks
Disney-backed Jaunt to focus efforts on AR, says some staff will be 'moving on' »

Jaunt, a top-funded VR…

DIS

Disney

$113.47

0.86 (0.76%)

GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

GOOGL

Alphabet Class A

$1,101.58

-19.41 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 08

    Nov

  • 03

    Mar

HMC

Honda

$27.05

-0.16 (-0.59%)

18:19
10/15/18
10/15
18:19
10/15/18
18:19
Hot Stocks
Honda to recall 54 model year 2017-2018 Honda Civic and Honda CR-V vehicles »

American Honda will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

MSFT

Microsoft

$107.60

-1.94 (-1.77%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Microsoft co-founder Paul Allen dead at 65 »

Vulcan Inc. released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

OII

Oceaneering

$25.69

0.4 (1.58%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Oceaneering provides update following Hurricane Michael »

Oceaneering International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

JOE

Saint Joe Co.

$15.28

0.01 (0.07%)

18:07
10/15/18
10/15
18:07
10/15/18
18:07
Hot Stocks
Saint Joe released additional information regarding Hurricane Michael »

The St. Joe Company …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.41

0.055 (0.36%)

18:05
10/15/18
10/15
18:05
10/15/18
18:05
Periodicals
Petrobras anticipates reviving TAG sale over next month, Reuters says »

Petrobras expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$238.05

-10.84 (-4.36%)

18:02
10/15/18
10/15
18:02
10/15/18
18:02
Hot Stocks
Adobe says it sees increased demand for PDF capabilities »

Says it has over 300,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.